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patients switching from older drug, Oxicam to new drugs, Coxibs. Deterministic 
model will help the hospital administrator understand pattern of drug use and its effect 
of ﬁ nancial management; however, clinical outcome should be included for further 
analysis. 
NEUROLOGICAL DISORDERS – Clinical Outcomes Studies
PND1
OUTCOME OF PHARMACIST INTERVENTION IN EDUCATION OF 
PATIENTS ON DUPLICATE PRESCRIPING HYPNOTIC-SEDATIVES
Chu LL1, Lin HC1, Huang HY1, Chan AL2
1Chimei Medical Center, Tainan, Taiwan; 2Chi Mei Medical Center, Tainan, Taiwan
OBJECTIVES: The inappropriate uses of hypnotic-sedatives will likely cause drug 
abuse. It has been known that patients visit different hospitals back and forth to get 
a duplicate prescription of hypnotic-sedatives. The purpose of this study is to explore 
the decrease of reﬁ ll frequency of prescribing sedative-hypnotics and drug cost. 
METHODS: This is a cohort study. Adult patients, who were prescribed two or more 
than two sedative-hypnotics with same pharmacological mechanism over a week by 
different physicians, will be retrieved from the claim database of a medical center in 
southern Taiwan. The retrieved patients were received a questionnaire to evaluate 
their knowledge about the appropriate use of hypnotic-sedatives before clinical phar-
macists provided patients with education for appropriate use of hypnotic-sedatives. 
The primary outcome was the reduction of total consumption on hypnotic-sedatives 
and drug cost before and after pharmacist education. RESULTS: A total of 100 
patients were included in this study. The results showed that about 62.8% of patients 
with duplicate use of hypnotic-sedatives were female and 59.1% of patients aged ³50 
years. Their chief complains was insomnia and/or anxiety which cannot be relieved 
by taking only one hypnotic-sedatives. The most frequently prescribed drugs in their 
duplicate prescription were zolpidem (30.45%), Fludiazepam (22.34%), Alprazolam 
(14.9%), Flunitrazepam (8.45%), and Brotizolam (7.93%). The average total con-
sumption on hypnotic-sedatives per day for each patient was decreased from 1.68 to 
1.33 tablets. The monthly hypnotic-sedatives costs were reduced form NT$ 21,000 
to NT $ 15,600. CONCLUSIONS: Pharmacist education on the appropriate use of 
hypnotic-sedatives and lifestyle management is likely to reduce the total consumption 
on hypnotic-sedatives and save drug costs. 
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WARFARIN-ASSOCIATED INTRACRANIAL HEMORRHAGE
Yang SC, Lin HL, Chan AL
Chi Mei Medical Center, Tainan, Taiwan
OBJECTIVES: To explore the possibility of international normalized ratio 
(INR),drug—warfarin interactions exaggerated intracerebral hemorrhage. 
METHODS: This is an observational study. Patients who had diagnoses of intracra-
nial hemorrhage (ICH,ICD-9-CM codes 430, 431, 432.0, 432.1, 432.9) from January 
2004 to December 2009 were retrieved from the claim database of a medical center 
in southern Taiwan. We reviewed medical records to identify the possible relationship 
with suspected risk factors, drug-warfarin interactions and ICH. Patients who were 
not taking warfarin at the time of hemorrhage and traumatic ICH were excluded. 
Potential drug interactions were deﬁ ned according to online drug interaction database 
of Lexi-InteractTM. Data were analyzed by multivariate logistic modeling. RESULTS: 
During the study period, 24 patients were deﬁ ned as ICH while patients were receiving 
warfarin. Forty-ﬁ ve percent of patients had an INR value >3.0 at admission to hospital 
and 25% were exceeded 5.0. The potential drug-warfarin interaction were antiplate-
lets (41.6%), allopurinol (16.6%), amiodarone (8.3%), NSAID (16.6%), others 
(16.6%).which may increased the bleeding risk. Five patients of 24 patients were died 
within 2 weeks. No correlation between the fatal cases and their gender, age, INR 
value, smoking, alcohol and comorbid diseases was founded. CONCLUSIONS: 
Although no correlation between drug–warfarin interaction, INR and ICH was found 
in this study, physicians should still need to inform patients, who are taking warfarin, 
to concern the potential interactions between herbs and over-the-counter medicines. 
NEUROLOGICAL DISORDERS – Cost Studies
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A RAPID REVIEW OF ECONOMIC EVALAUTIONS OF DONEPEZIL, 
RIVASTIGMINE, GALANTAMINE AND MEMANTINE FOR ALZHEIMER’S 
DISEASE (AD)
Feng J, Huang R, Pwee K
Ministry of Health, Singapore
OBJECTIVES: To review the cost-effectiveness of cholinesterase inhibitors (ChEIs; 
donepezil, galantamine and rivastigmine) and memantine for treating patients with 
AD. This review aims to inform policymakers in Singapore on the published cost-
effectiveness studies of these drug therapies. METHODS: Electronic databases 
(EMBASE, MEDLINE, NHS EED) were searched from inception to February 2010 
for published economic evaluation studies. Additional references were identiﬁ ed 
through searching bibliographies of included studies and related publications. Review 
papers of economic evaluations either on individual drugs or more of these drugs were 
considered. An outline assessment of economic evaluations was undertaken using 
Drummond’s checklist. RESULTS: A systematic search of the literature identiﬁ ed 32 
economic evaluations (2 of all three ChEIs, 11 of donepezil, 5 of rivastigmine, 7 of 
galantamine, and 7 of memantine). All studies used clinical trial data from single drug 
comparisons with placebo. Different approaches have been used to model disease 
progression for evaluating cost-effectiveness of each drug, making comparison 
between drugs more difﬁ cult. Caro et al. (2003) and Green et al. (2005) considered 
the three ChEIs using a common analytical framework. Most of the studies reported 
that drugs provided health beneﬁ ts and cost savings over time, suggesting that their 
use was cost-effective. However, Green et al. (2005) concluded that treatment with 
ChEIs may not be cost effective from the UK NHS’s perspective. CONCLUSIONS: 
The majority of economic evaluations of ChEIs and memantine reported that these 
treatments were the dominant strategies compared with no treatment. However, 
conclusions from the reviews of economic analyses were mixed, and the authors com-
mented that the ﬁ ndings from economic analyses of these four drugs should be 
interpreted with caution due to the assumptions and methodology used. Comparison 
between studies is difﬁ cult due to difference in study types, geographic locations, 
perspectives and different assumptions within the models. 
RESPIRATORY-RELATED DISORDERS – Clinical Outcomes Studies
PRS1
RISK OF SERIOUS ASTHMA EXACERBATIONS ASSOCIATED WITH 
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ASTHMA: A RETROSPECTIVE COHORT STUDY
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OBJECTIVES: Concerns have been raised that the use of long-acting-beta-agonists 
(LABAs) may be associated with an increased risk of serious exacerbations (SAEs). 
We proposed to examine the association between LABAs and SAEs among patients 
with asthma in a large Medicaid population. METHODS: A total of 1,117,850 
patients with asthma were selected for this study using a multi-state Medicaid claims 
database. The study period was January 1, 2002 to December 31, 2007. SAEs included 
any primary asthma diagnosis for either hospitalization, emergency room visits, or 
intubation. Major asthma medications included in the analysis were inhaled cortico-
steroids (ICS), LABAs, ICS/LABA combinations, short-acting-beta-agonists, leukotri-
ene modiﬁ ers, and methylxanthines. Asthma severity levels were deﬁ ned by patient’s 
treatment regimens based on the national asthma guideline. Cox proportional hazard 
regression was conducted to assess the risk of SAEs associated with the use of LABAs, 
ICS/LABA combinations, and other covariates. RESULTS: Based on the ﬁ rst 6 months 
of wash-out period, we identiﬁ ed 550,392 patients with newly diagnosed and 567,458 
patients with preexisting asthma. A total of 197,283 (35.8%) newly diagnosed and 
242,207 (42.7%) preexisting patients had at least one SAE during the study period. 
After controlling for covariates, the risk of SAEs was relatively low among newly 
diagnosed patients taking salmeterol (hazard ratio [HR] = 0.93, 95% conﬁ dence 
intervals [CI] 0.89–0.97), formoterol (HR = 0.88, 0.83–0.94), and ICS/LABA combi-
nation (HR = 0.88, 0.87–0.90). Meanwhile, the risk of SAEs was mixed among pre-
existing asthmatic patients taking salmeterol (HR = 1.03, 1.01–1.04), formoterol (HR 
= 0.94, 0.90–0.97), and ICS/LABA combination (HR = 1.01, 1.00–1.02). Other key 
risk factors (P < 0.0001) were associated with African-American, severe or moderate 
asthma, use of oral steroids, alcohol or substance disorder, depressive disorder, preg-
nant women, obesity, and upper respiratory tract infection. CONCLUSIONS: The 
risk of SAEs should be considered when treating patients with asthma, especially for 
patients with key comorbidities as well as African-American patients and pregnant 
women. 
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ASSESSMENT OF KNOWLEDGE ABOUT TUBERCULOSIS AMONG TB 
PATIENTS IN NORTH EAST LIBYA
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OBJECTIVES: To evaluate the knowledge toward the etiology and treatment of Tuber-
culosis (TB) among TB patients in North Eastern Libya. METHODS: Face to face 
interview with all TB Patients in 2009 was conducted at Kuwaiﬁ a and Shahat Chest 
Hospitals in North Eastern Libya. Questionnaire included questions related to the 
knowledge about transmission, diagnosis; risk factors, treatment and prevention of TB. 
A total of 140 patients participated in this study. Knowledge scores ranged from zero 
(minimum score) to 23 (maximum score). All data was analyzed using SPSS version 
15.00®. Inferential statistics were used as whenever appropriate. P-value of less than 
0.05 was considered signiﬁ cant. RESULTS: Majority of the respondents were Libyans 
(n = 92, 65.7%). Fifty-ﬁ ve (39.3%) of the respondents were males, and up to 90 subjects 
(64.3%) were urban residents. Almost all of the respondents have heard about TB. 
Nearly (n = 70, 50.0%) shared a thought that the main source of their knowledge 
regarding TB were health workers, followed by television (n = 63, 45.0%), and family 
members (n = 34, 24.3%). Libyans have signiﬁ cantly better knowledge (12.26 ± 4.33) 
than non Libyans (7.85 ± 4.83, t = 30.12, P < 0.001). In addition those respondents 
with tertiary educations scored signiﬁ cantly higher knowledge score (15.7 ± 4.2) com-
pared to those of intermediate (15.3 ± 3.8) and illiterate (9.4 ± 3.5), [F = 30.12, P = 
